What does Nicovast do?
NICOVAST is a company specializing in the development and production of innovative nicotine replacement therapies. It focuses on providing effective solutions for smoking cessation while ensuring consumer safety and compliance with health regulations. The company aims to enhance the overall well-being of its customers through its scientifically backed products.
- Activities
- Signals
-
Poor liquidityPoor liquidity 0.25
The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 248KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 2.05MStrong equity provides a buffer against setbacks.
Low riskLow risk 63.4%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 294KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 68KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 10.7%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
242K
|
€
249K
|
€
358K
|
€
316K
|
|
|
€
68K
|
€
59K
|
€
177K
|
€
209K
|
|
|
€
248K
|
€
149K
|
€
174K
|
€
755K
|
|
|
€
2.05M
|
€
1.86M
|
€
1.78M
|
€
1.61M
|
|
|
63.37%
|
57.82%
|
53.91%
|
46.72%
|
|
|
€
1.17M
|
€
1.34M
|
€
1.51M
|
€
1.82M
|
|
|
€
7K
|
€
18K
|
€
11K
|
€
27K
|
Publications 12
All publications- Kapitaal - Aandelen - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 18/07/2019
- Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 03/05/2019
- Me. - Jaarrekening 31.12.2015, Ggk 25.06.2016, Ngl 06.07.2016 16287-0107-014 14/07/2016
- Me. - Jaarrekening 31.12.2014, Ggk 27.06.2015, Ngl 29.06.2015 15241-0368-014 06/07/2015
- Me. - Jaarrekening 31.12.2013, Ggk 28.06.2014, Ngl 14.07.2014 14306-0091-012 18/07/2014
Frequently asked questions
Answers to the most common questions about Nicovast, based on official government data and the filed annual accounts.
What is the VAT number of Nicovast?
The VAT number of Nicovast is BE0890.901.052.
When was Nicovast established?
Nicovast was founded in 17-07-2007.
What is the official address of Nicovast?
The official address of Nicovast is Kasteelstraat 9 Gavere 9890.
What is the legal form of Nicovast?
The juridical form of Nicovast is Private limited company (BV/SRL).
What is the annual revenue of Nicovast?
The revenue of Nicovast for the 2025 financial year was €242,372.
What does Nicovast do?
NICOVAST is a company specializing in the development and production of innovative nicotine replacement therapies. It focuses on providing effective solutions for smoking cessation while ensuring consumer safety and compliance with health regulations. The company aims to enhance the overall well-being of its customers through its scientifically backed products.
Is Nicovast a reliable company?
Nicovast is a registered Rechtspersoon with company number 0890.901.052 and can be verified through the official CBE database.
What is the credit limit of Nicovast?
The estimated credit limit of Nicovast is €202,016.
Is Nicovast still active?
Nicovast currently has the status "Normal situation" and is active.